Please search for your last name

Finnish Vaccine Research Center Finvac Ltd
Department of pragmatic trials and register studies
Chief research officer, Finnish Vaccine Research Center Finvac Ltd (April 1, 2022 onwards) arto.palmu@finvacresearch.com Research manager (part-time), Finnish Institute for Health and Welfare, THL arto.palmu@thl.fi MD, PhD, university lecturer in clinical epidemiology, specialist in public health medicine. Dr Palmu’s key research interests are in pneumococcal and influenza infections and their prevention by vaccines, and he has published more than 70 papers in peer-reviewed journals. His primary expertise is on clinical trials and register-based research, and he has been pivotal in the development of the combination of clinical trial design with real-world evidence (RWE) from the national health registers. Dr Palmu has worked as a researcher at the Finnish Institute for Health and Welfare (THL) based in Tampere since 1995. Since April 2022, he joined the Finnish Vaccine Research Center Finvac Ltd, which was established to merge THL and Tampere University teams working on clinical vaccine research conducted in collaboration with the vaccine manufacturers. Arto A. Palmu was the primary coordinator and co-investigator for the pivotal Finnish Invasive Pneumococcal (FinIP) disease vaccine effectiveness trial which was the first randomised clinical trial to measure the effectiveness of PCV10 and the largest PCV trial ever conducted in children.
National and Kapodistrian University of Athens, 'Agia Sophia' Children's Hospital
1st Department of Pediatrics, Immunobiology and Vaccinology Research Laboratory
Ioanna earned her Medical Degree in 2009 (Cum Laude) and her PhD in 2015 (Summa Cum Laude) from Athens Medical School, NKUA (Monograph: Memory B cell response to pneumococcal vaccination in asplenic patients). Since the completion of her PhD she has an continuous engagement in pediatric infectious diseases and vaccinology research. In parallel with her research work, she has completed her clinical training in Pediatrics both in the UK (2012-2014) and Greece(2016-2019). For her post-doctoral research, she has been awarded a Small Grant Award by ESPID(2015-2016) for her work on vaccine-induced memory T cells; the Robert Austrian Research Award for pneumococcal Vaccinology (2016) & an Early Career Grant (2020)for her work on vaccine-induced memory B cells and most recently the ESPID Fellowship Award (2020) for her work on Systems Analysis of the immune response to pneumococcal vaccination- including transcriptional profiling- in collaboration with Emory University, USA. She has authored several peer-reviewed scientific papers and presented in numerous international meetings. Joanna is married and is a mum of two boys.
no photo
Sceinsano
Infectious Diseases Human
no photo
Fundación Valle de Lili
Infectious diseases
no photo
Jawaharlal Institute of Postgraduate Medical Education and Research
Microbiology
no photo
Research Center in Infectious Diseases, CHU de Québec – Laval University
Microbiology and immunology
Murdoch Children's Research Institute
Infection and Immunity
I am a Senior Research Assistant at the Murdoch Children's Research Institute. For over 10 years, our team has worked to detect the pneumococcus. I have a particular interest in the transport of samples, and identification and serotyping of this bacteria.
Boston Medical Center
Pediatric Infectious Diseases
Stephen I. Pelton is Professor of Pediatrics at Boston University Schools of Medicine in Massachusetts. He is the former Director of Pediatric Infectious Diseases at Boston Medical Center (BMC) and Coordinator of Maternal Child HIV Program. Professor Pelton received his medical degree from the State University of New York, Buffalo School of Medicine. He completed a residency in pediatrics at BMC and fellowship in pediatric infectious diseases at Harvard Medical School at the Channing Laboratory at Boston City Hospital. He is board certified in Pediatric Infectious Diseases and Pediatrics by the American Board of Pediatrics. Professor Pelton is an active clinician, investigator, a member of the Boston Medical University Campus Institutional Review Board, and mentor for trainees in pediatric infectious diseases at Boston Medical Center. His laboratory is focused on vaccine-preventable diseases, especially those due to Streptococcus pneumonia, and new vaccines for prevention of respiratory tract infection due to nontypeable Haemophilus influenzae. Professor Pelton’s work has led to his recognition as a leading clinical scientist in studies of the impact of pneumococcal conjugate vaccine on invasive and respiratory tract disease in children. Recent studies include studies of immunogenicity and safety of pneumococcal conjugate vaccines in HIV infected children, studies of immunogenicity and safety of a novel pneumococcal conjugate vaccine (adjuvanted with MPL) in infants, as well as studies of the burden of pneumococcal disease in children and adults with comorbid conditions. He has authored more than 150 manuscripts including publications in The New England Journal of Medicine, Clinical Infectious Diseases, The Journal of Pediatrics, Vaccine, and Pediatric Infectious Disease Journal.
no photo
University of Edinburgh
Centre for Inflammation Research
Pfizer Inc.
Global Health Economics and Outcome Research
Yale University School of Public Health
Epidemiology of Microbial Diseases
I'm an Associate Research Scientist in the Public Health Modeling Unit at the Yale School of Public Health. My work involves surveillance and analyses of pneumococcal epidemiology, pneumococcal vaccines, and pneumococcal vaccination strategies. I was raised in the midwestern United States, but have also lived in Mexico, Spain, and Germany. I earned my doctorate in Medical Microbiology from RWTH Aachen in 2019, during which I worked at the German National Reference Center for Streptococci. My non-work interests include hiking, science fiction, and gardening. This year, we're growing grapes, strawberries, blueberries, raspberries, pumpkins, and peppers.
University of Utah
Pediatric Infectious Disease
Nicole Pershing is a Pediatric Infectious Disease physician scientist at the University of Utah. She completed her pediatric infectious disease fellowship at the University of Utah in 2021, working with Dr. Anne Blaschke studying the genomic evolution of pneumococci causing invasive disease among Utah children. She is currently conducting postdoctoral research in Dr. June Round’s lab studying the influence of bacterial prophage on mucosal response to bacterial pathobionts. She is interested in the complex interplay between bacteria, their lysogenic phage, and mammalian immune responses governing pathophysiology of bacterial colonization versus invasive disease. Nicole completed a BS in biology at MIT, and MD/PhD at Duke University. She lives in Salt Lake City, Utah where she enjoys exploring the great outdoors with her family.
no photo
Rochester General Hospital Research Insititute
Center for Infectious Diseases and Immunology
no photo
Instituto Butantan
Biotechnology Department
no photo
Facultad de Medicina, Unviersidad de la República
Clínica Pediátrica A
no photo
Patan Academy of Health Sciences
Paediatrics
no photo
Nigeria Center for Disease Control (NCDC)
National Reference Laboratory
no photo
Patan Academy of Health Sciences
MIcrobiology
no photo
Centers for Disease Control and Prevention
National Center for Immunization and Respiratory Diseases, Division of Bacterial Diseases